1. Immune disorders
• immunity & immune disorders - extreme
importance (comparable to bacteriology at
the early 20th cent.)
• new diseases, immunological etiology in
"old" diseases, immunotherapy -
considerable amount of medical information
• immune system - important for survival
• increased or decreased immunity - disease
2. Introduction
• humoral & cellular immunity
• B-lymphocytes - plasma cells - Ig A, M, G, E, D
• lymph nodes - cortex - germinal centers
• T-lymphocytes (60-70% in peripheral blood)
• lymph nodes - paracortex
• subspecialization (helper, suppressor, killer,
natural killer)
3. Introduction
• Macrophages
• Antigen-presenting cells - dendritic cells,
Langerhans cells (skin)
• MHC system
• HLA complex antigens - ability to recognize own
Ag from foreign ones
• importance in transplantation - rejection
(destruction of the graft by host)
5. I. Anaphylactic type
• quickly developing after contact of Ag (allergen)
with Ab
• previous exposition!
• B-cells - IgE
• mediated through histamine, leucotriens,
prostaglandins (granules of mast cells &
basophilic leucocytes)
• increase of vascular permeability, vasodilatation,
bronchoconstriction, increased mucoproduction
6. • local reaction - skin or mucosa
• bee sting, food allergy, hay fever (pollinosis),
asthma bronchiale, urticaria (hives)
• familiar predisposition - atopy
• systemic reaction
• parenteral administration of Ag (e.g. antiserum,
drug-ATB) - systemic anaphylaxis -> anaphylactic
shock
• minutes - itching, rush, redding of skin
• breathing problems, abdominal pain, vomiting,
diarrhea
• during several min - death due to collapse of
circulation
7. II. Antibody dependent type
• antigens - autologous (own) or homologous
(another human)
• incompatible blood transfusion - destruction
of RBCs
• Rh-incompatibility - fetal erythroblastosis
(anti-Rh Ab)
8. III. Immune complex diseases
• formation of Ag-Ab complexes (immune
complexes)
• activation of complement and accumulation of
polymorphonuclear leucocytes
• acute inflammation of tissues
• e.g. serum sickness - repeated exposure to animal
(equine) serum (antitetanic)
• immuncomplexes are deposited in tissues -
inflammation
9. • vessel wall - acute necrotizing vasculitis
(fibrinoid necrosis) - thrombosis - ischemic
necrosis
• vessel wall replaced by smudgy, pink
material
• local form of IS - Arthus reaction (animal
model - skin lesion) - localized area of
tissue necrosis resulting from immune
complex vasculitis - farmer's lungs (molds
on hay)
• some types of glomerulonephritis
• systemic lupus erythematodes (SLE)
10. IV. Delayed type of hypersensitivity
(tuberculin-type) - cell mediated
• cellular immunity - T-cells&histiocytes
• frequently granulomatous reaction (epithelioid
cells)
• TBC, syphilis, leprosy
• e.g. tuberculin reaction - Mantoux test
• person previously exposed to TBC develops after
intradermal injection of Ag skin induration
• manifestation after 8-12 h, maximum 2-7 weeks
11. Transplantation rejection
• transplantation:
• - autologous (own)
• - homologous (alogenic) - human tissue
• - heterologous - animal tissue (pig skin,
ovine pericardium)
• both humoral and cellular immunity - HLA
system
13. Graft versus host disease
(GVHD)
• in transplantations of allogenic
hematopoietic cells
• immunologically competent donor cells
transplanted into immunologically
compromized recipient
• donor's T-cells react against "foreign"
recipient's tissues
• liver, skin, gut
14. 2. Autoimmune diseases
• immune system reacts against own Ag
• A. Organ specific
– Hashimoto's thyroiditis
– Graves-Basedow disease
– chronic atrophic gastritis - pernicious anemia
– DM type I.
• B. Systemic (multiorgan)
• affection of vessels and/or connective tissue,
variable symptomatology
– systemic disorders of connective tissue (collagenosis)
– rheumatic fever
15. Systemic lupus erythematosus
(SLE)
• febrile inflammatory multisystemic disease -
variable symptomatology
• females (F:M = 10:1), 2.-3. decade
• most often affected: skin, kidneys, serosal
membranes, joints, heart
• several types of Ab - namely antinuclear Ab
• formation of immuncomplexes
• histologically - predominantly necrotizing vasculitis
• LE cells (fagocytosis of hematoxylin bodies -
destroyed nuclei of cells) - lab test
16. Symptomatology
• Skin - facial exantema (butterfly) - cheeks+radix of the nose
• Pleura+pericardium - serous and fibrinous exsudation - fibrosis
• Heart - pericarditis
• endocarditis Libman-Sacks (verrucous) - nonbacterial thrombotic
endocarditis
• both sides of the valve
• Kidneys - various forms of Glnf
• Joints - swelling, inflammation
• Spleen - thickening of the capsule (serositis)
• concentric perivascular fibrosis (onion-like)
17. Typical clinical presentation
• young female, butterfly-shaped exantema of the
face
• febrile, joint pain, pleuritic pain, photophobia
• ANCA+
• !!!CAVE!!! frequently atypical symptomatology
• clinical course:
• progressive - death
• recurrences and remissions - years or decades
• treatment: steroids, immunosupression
18. Rheumatoid arthritis (RA)
• symetric chronic inflammation of the joints
• non-purulent productive synovitis - pannus
(granulation tissue)
• destruction of cartilage - progressive
impairment of function
• rather frequent: females 0,5-4%, males 0,1-
1,3% (F:M=3-5:1)
• usually young adults
19. • pathogenesis - both humoral and cellular
immunity
• increased Ig in serum
• "rheumatoid factor"
• clinically:
• symetric inflammation of small joints (hands and
feet), later also ankle, wrist, elbow, shoulder, jaws
• only rarely hips
• deformation and loss of function of joints
• sometimes formation of subcutaneous nodules (2-
3 cm in diam.) - rheumatoid nodules
20. Special forms of RA
Juvenile RA (Stil‘s disease) - age 1-3 y.
• RA + fever, hepatosplenomegaly,
lymphadenopathy
Felty's disease
• RA + splenomegaly + leukopenia
21. Systemic sclerosis (SS)
• interstitial tissue of various organs - inflammation and
fibrosis
• in 95% skin (scleroderma)
• sometimes visceral lesions (GI tract, lungs, kidneys,
heart, muscles) = most important
• F:M=3:1
• any age (childhood - old age), mainly 3.-5. decade, rare
• histologically:
• sclerosis of collagen (loss of filamentous structure,
homogenization, hyalinization, no nuclei)
22. • skin - fingers - progression proximally
• first edema, than sclerosis of collagen,
atrophy of epidermis, loss of skin adnexa
• skin is dry, with smooth surface, shiny, thin
- ulceration
• loss of elasticity, rigidity
• spontaneous amputations, mask face
23. GI tract
• namely esophagus - atrophy and fibrosis of the
wall - problems with swallowing
Locomotory apparatus
• loss of mobility, rigidity
Lungs
• interstitial fibrosis
Heart
• interstitial fibrosis of myocardium
Vessels
• Raynaud's phenomenon - polyarteritis nodosa
24. Polymyositis (dermatomyositis)
• symetrical muscle weakness, pain, swelling,
atrophy
• 2 peaks of incidence - 5-15 y., 50-60 y.
• frequently combination with other systemic
diseases - overlap syndromes, vasculitis
• mixed connective tissue disease
25. Polymyositis (dermatomyositis)
Histologically
• inflammation (lymphocytes, plasma cells,
histiocytes)
• atrophy, necrosis, disappearance of muscle fibres,
replacement by fibrous tissue and fat
• usually starts proximally (shoulder, pelvis) - distal
progression
• in 10-20% combination with malignant tumors -
ca lungs, GIT (males) or ca breast, ovary (females)
26. Sjögren's syndrome
• dry eyes (keratoconjuctivitis sicca) - corneal lesions
• dry mouth (xerostomia)
• caused by loss of salivary and lacrimal glands -
immunologicaly induced inflammation
• only salivary glands - benign lymphoepithelial lesion
(myoepithelial sialoadenitis) - see Mikulicz's sy
• salivary glands + lacrimal glands - sicca syndrome
• combination with other autoimmune disorders (RA -
60%) - Sjögren's sy - 1933
• involvement of glands of other systems (nose,
pharynx, vagina)
27. • histologically:
• lymphoid infiltrates, atrophy - loss of parenchyma
• mostly females, over 40 y.
• Dx. based on histology (excision of minor salivary
gland)
• Mikulicz's syndrome
• bilateral swelling of lacrimal glands, parotis and
submandibular glands
• various etiology (leukemia, lymphoma, syphilis,
TBC) + cases with unknown etiology - Mikulicz's
disease
28. Polyarteritis (periarteritis) nodosa
• necrotizing inflammation of the wall of middle
sized and small arteries - necrotizing vasculitis
• deposition of immuncomplexes (similar to
Arthus's phenomenon)
• often segmentally (uninvolved skipped areas) -
thrombosis - infarctions
• variable clinical presentation - most frequently
kidneys, heart, liver, GIT (perforation!), lungs
rarely!
29. Polyarteritis (periarteritis) nodosa
• histologically:
• fibrinoid necrosis (eosinophillic),
infiltration by neutrophillic leucocytes,
microaneurysms - rupture or thrombosis -
infarction
• healing by scar (fibrous tissue)
• M:F=2:1 (!predominance of males!)
• Dx. based on histology - diagnostic excision
32. A. Primary immunodeficiency
states
• experiments of nature, extremely rare
X-linked agammaglobulinemia (Bruton's disease)
• inability of pre-B cells to diff. into mature B-cells
• decrease in circulating B-cells, no germinal centers in
LN, rudimentary Peyer's patches
• recurrent bacterial infections (H. influ., Str. pneumon.,
Staph. aur.)
Isolated deficiency of IgA
• most frequent (1:700)
• recurrent sinopulmonary infections, diarrhea
33. Thymic hypoplasia (DiGeorge's syndrome)
• congenital malformation of 3rd and 4th
branchial pouches
• vulnerability to viral, fungal and protozoal
infections
Severe combined immunodeficiency
• X-linked or autosomal recessive
34. B. Secondary immunodeficiency
states
• more common
• in malnutrition, infection, cancer, renal
disease, malignancies
• patients treated by immunosupressive drugs
• AIDS
35. Acquired immunodeficiency
syndrome (AIDS)
• viral etiology (HIV, RNA retrovirus)
• severe immunosupression - opportunistic infections, secondary
tumors, neurologic symptoms
• first recognized 1981 - Los Angeles - pneumocystic pneumonia
in 5 young homosexuals - 2 died
• Pneumocystis carinii (interstitial pneumonia in premature
infants)
• onset of epidemic
• 1998 - 33,4 million of infected (22,5 in sub-Saharian Africa)
• number of both infected and ill patients increases - USA, Africa
(2/3 of all cases in the world), Southeast Asia (Thailand, India,
Indonesia)
36. Transmission
• 1. sexual contact (lymphocytes in semen)
• 2. parenteral - blood + derivates, drug abusers
sharing needles
• 3. mother-to-infant - transplacental, intrapartum,
breast-feeding
• HIV cannot be transmitted by casual personal
contact !!!
• No transmission from patient to doctor (and
vice versa) by casual contact !!!
• Prevention of injury - needle sticks, etc.;
operation or autopsy - special precautions
37. Epidemiology - 6 risk groups
• 1. homosexual males (60%)
• 2. intravenous drug abusers (24%)
• 3. hemophiliacs (1%)
• 4. other blood recipients (2%)
• 5. heterosexual partners of other high-risk
groups members
• 6. children of parents from groups 1.-3.
38. • HIV-1 and HIV-2 - closely related
• long incubation period
• tropism for lymphocytes and nervous
system
• immunosupression - CD4+ T-cells (helpers)
• slowly progressive fatal outcome
40. Neoplasms in AIDS
• Kaposi's sarcoma (sarcoma idiopathicum
hemorrhagicum multiplex) - related to HSV
infection
• non-Hodgkin's ML (Burkitt's or
immunoblastic)
• primary ML of CNS
• invasive ca of uterine cervix
41. "Typical" patient in the USA
• young male homosexual or drug abuser
• fever, weight loss, diarrhea, generalized
lymphadenopathy, multiple opportunistic
infections, neurologic disorders, secondary
neoplasm(s)
"Classical" clinical course
• after infection 4-7 W -> seronegative period ->
seroconversion -> long latency (2-5 Y) ->
lymphadenopathy -> AIDS-related complex (ARC
- fever, weight loss, diarrhea) -> AIDS
• no vaccine, no drugs, only prevention
• AIDS - 100% mortality
42. IV. Amyloidosis
• amylum = starch; amyloid = starchlike
• abnormal proteinaceous substance deposited
between cells in many tissues and organs
• intercellular pink translucent material
• variety of clinical disorders
43. • A. = not a single chemical entity
• two major and several minor biochemical
forms
• several pathogenetically different
mechanisms
• unique tertiary structure - ß-pleated sheet
conformation
• responsible for staining properties and for
resistance to enzymes
44. Chemical nature of amyloid
• two types
• immunoglobulin light chains - AL (amyloid
light chain) - in B-cell disorders
• nonimmunoglobulin protein - AA (amyloid
associated) - in chronic inflammations
Classification of amyloidosis
• systemic - kidneys, liver, spleen, adrenals,
lymph nodes
• localized - various organs
45. Systemic amyloidosis
1. primary - immunocyte dyscrasias
• deposition of AL-A., produced by aberrant clones of B-cells -
most frequent form
• A. in multiple myeloma
• monoclonal proliferation (neoplasm) of plasma cells - monoclonal
gammopathy
• multiple osteolytic lesions of the bones
• in addition to monoclonal Ig - production of isolated kappa or
lambda light chain (Bence-Jones protein)
• only 6-15% of patients with MM develop amyloidosis
• other cases of primary A. - e.g. light chain disease
• other B-cell related disorders
46. 2. secondary amyloidosis
• reactive AA amyloid - protracted
breakdown of cells, usually in chronic
inflammatory disorders
• TBC, osteomyelitis, bronchiectasis
• RA, connective tissue disorders, ulcerative
colitis, tumors (Hodgkin's ML)
47. Localized amyloidosis
• heterogenous group
• nodular deposits - lungs, larynx, skin, urinary
bladder, tongue - infiltration of B-cells - probably
well differentiated plasmacytoma
• special forms:
• AE - endocrine tumors (medullary ca of thyroid)
• AS - senile amyloid (brain, heart)
48. Staining of amyloid
Gross reactions
• Virchow I. - staining by Lugol's sol.
• Virchow II. - reaction with H2SO4
Microscopy
• metachromasia (cresyl violet, gentian violet)
• Congo red - green birefringence
• monoclonal antibodies against different types of
amyloid - more precise classification
49. Involvement of organs
Kidneys
• most common, most serious
• glomeruli, vessels, peritubular stroma
• nephrotic syndrome
Spleen
• two types - follicular (sago) and diffuse (lardaceous) spleen
Liver
• weight up to 9kg!
• space of Disse - atrophy of hepatocytes
Heart
• AS-amyloid - left atrium (ANF granules)
• AA - in systemic involvement - firm, wax-like
50. Clinical symptomatology
• incidental finding at autopsy
• severe clinical symptoms - renal
malfunctions, hepatosplenomegaly, heart
involvement
• Dx.: needle biopsy of lesion; in systemic -
biopsy of rectal or oral mucosa
